Advertisements

Nitrolingual akut

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Nitrolingual akut

Property Description
Active ingredient Nitroglycerin (Glyceryl Trinitrate, GTN)
Form Metered-dose sublingual spray, solution
Pharmacological class Nitrate vasodilator, Antianginal agent
General use Acute relief of sudden chest discomfort
Origin Synthetic, Single-ingredient product

Nitrolingual akut is a prescription-only medicine used for the rapid, on-demand management of acute chest discomfort. It is classified as an antianginal agent and a nitrate vasodilator, characterized by its delivery as a unique, metered-dose sublingual spray.


Defining the Nitrolingual akut Entity: Active Ingredient and Class

The active ingredient in Nitrolingual akut is Nitroglycerin, which is chemically referred to as glyceryl trinitrate (GTN). This agent is a synthetic compound belonging to the pharmacological class of organic nitrates. The clinical application of GTN as an acute therapeutic agent is based on its immediate effects on vascular smooth muscle. The medicine is a single-ingredient product presented as a solution dispensed by a pump spray, which contains GTN along with a non-aqueous solvent, such as ethanol, and a propellant.


The Form and General Purpose of the Sublingual Spray

Nitrolingual akut is specifically a sublingual spray, meaning the solution is administered directly onto or under the tongue for rapid absorption into the bloodstream. This mucosal route of administration allows the Nitroglycerin to bypass the initial metabolic breakdown that occurs in the liver, enabling the drug to reach the systemic circulation almost immediately. This characteristic defines the general therapeutic purpose of the product: to provide acute relief when a patient experiences sudden symptoms of chest pain requiring immediate intervention.


How Nitroglycerin Differs from Other Acute Medications

The essential function of GTN is to induce widespread vasodilation, which is the relaxation and expansion of blood vessel walls, predominantly in the systemic veins. This mechanism reduces the volume of blood returning to the heart, which in turn reduces the heart's workload and oxygen demand. This action is facilitated because this organic nitrate provides a source of nitric oxide (NO), a natural signaling molecule that mediates muscle relaxation, making it an agent for the immediate reduction of cardiac stress compared to less direct-acting antianginal agents.

Regulatory References

  1. Nitroglycerin - StatPearls - NIH
Advertisements

What side effects are possible with Nitrolingual akut?

The official safety information for Nitrolingual akut (Nitroglycerin sublingual spray) is documented in governmental regulatory labeling, outlining specific adverse reactions and safety constraints. The side effect profile is largely characterized by effects resulting from its vasodilatory action.

Frequency-Classified Adverse Reactions

Adverse reactions are categorized by their frequency of occurrence, based on regulatory standards:

  • Very Common (reported in ge 1/10 patients): Headache. This is often noted as the most prominent reaction.
  • Common (reported in ge 1/100 to < 1/10 patients): Dizziness, Orthostatic Hypotension (postural low blood pressure), Facial Flushing, and Tachycardia.
  • Uncommon (reported in ge 1/1,000 to < 1/100 patients): Nausea, Vomiting, and Syncope (fainting).

Serious Safety Considerations

The label documents serious adverse reactions, which include Severe Hypotension and Circulatory Collapse. A paradoxical worsening of chest pain, known as Aggravated Angina Pectoris, has also been noted. Use is absolutely contraindicated when patients are taking Phosphodiesterase-5 (PDE5) inhibitors (e.g., sildenafil) or sGC stimulators, as this combination carries a high risk of life-threatening severe hypotension.

Safety Context and Constraints

Certain time-related patterns are noted in the safety documentation: effects like headache are often more prominent at the start of treatment and may diminish with continued use. Older adults may have an increased susceptibility to hypotensive effects. Other documented safety constraints include avoiding use in patients with severe anemia or conditions associated with increased intracranial pressure.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The information in this section is based on documented findings and requirements in official governmental regulatory documents (e.g., FDA, EMA-equivalent prescribing information).

Documented Manifestations of Overdose

An overdose of Nitroglycerin is primarily characterized by a severe exaggeration of its effects, stemming from widespread vasodilation. Documented manifestations include severe hypotension (low blood pressure), persistent, intense throbbing headache, reflex tachycardia, dizziness, vertigo, syncope (fainting), and general weakness. Severe outcomes noted in regulatory labeling include circulatory collapse or shock.

At high doses, a serious complication known as Methemoglobinemia may occur. This condition is signaled by symptoms such as cyanosis and difficulty breathing and requires specific medical intervention.

Required Emergency Actions

Official regulatory labeling defines a specific threshold for seeking urgent medical care:

  • Immediate Medical Attention: You must seek immediate emergency medical help if chest pain persists after using a total of three metered sprays within a 15-minute period.

Supportive Treatment in Overdose

Treatment described in regulatory sources focuses on supporting blood pressure and circulation. This may involve elevation of the legs and intravenous volume replacement for pronounced hypotension. The official labeling also lists Methylene Blue or Vitamin C as antidotes for Methemoglobinemia. It is specifically noted that the use of epinephrine is contra-indicated in the management of nitroglycerin overdose.

Advertisements

Therapeutic Uses of Nitrolingual akut

What Nitrolingual akut Treats: Main Uses and Benefits

Nitrolingual akut is generally considered relevant for symptomatic support in patients managing Coronary Artery Disease (CAD), offering assistance focused on the symptomatic control of chest discomfort. The medication is commonly used in therapeutic contexts associated with the acute relief and prophylaxis of angina, which is the primary therapeutic area.

The medicine is applied across domains where additional symptomatic support is needed, particularly for managing acute attacks and providing prophylactic assistance. It helps address symptom clusters that may become intense, such as sudden squeezing, pressure, or heaviness in the chest. This medication is relevant for easing symptoms that interfere with daily comfort in specific clinical scenarios: the immediate acute relief of an ongoing anginal episode and acute prophylaxis before engaging in activities known to provoke chest pain (e.g., strenuous exertion or emotional stress).

“The medication is applied in scenarios where symptoms are highly likely to occur, supporting patients during difficult episodes.”


Quick Fact: Relief for Acute Angina
Primary Use: Symptomatic support for anginal chest discomfort and acute symptomatic management before predictable activity.
Benefits: Provides support that helps ease the overall symptom load and assists with maintaining functional stability during episodic manifestations.
Advertisements

Eligibility and Restrictions for Use

Nitrolingual akut (which contains nitroglycerin) is prescribed for the relief of sudden chest pain (angina pectoris).

However, its use is contraindicated in specific patient groups to prevent serious adverse effects. The most critical contraindication is the simultaneous use of medications for erectile dysfunction (PDE-5 inhibitors), such as sildenafil, vardenafil, or tadalafil, or soluble guanylate cyclase (sGC) stimulators, like riociguat, as this can cause a severe, life-threatening drop in blood pressure.

Do Not Use If You Have Use With Extreme Caution If You Have
Allergic reaction to nitroglycerin or other nitrates Low blood pressure (hypotension)
Acute circulatory failure or shock Severe anemia
Severe low blood pressure (hypotension) Recent heart attack or other serious heart conditions
Increased pressure in the head (e.g., from cerebral hemorrhage or head trauma) Hypertrophic cardiomyopathy
Concomitant use of PDE-5 inhibitors or sGC stimulators Pregnant or breastfeeding (use only if clearly necessary)

Patients should also exercise caution if they have conditions like severe anemia or certain heart conditions, such as hypertrophic cardiomyopathy. It is also not typically recommended for use in children.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for nitroglycerin sublingual spray products defines specific substances that must not be used with this medicine due to the risk of severe and life-threatening hypotension (dangerously low blood pressure).

Prohibited Combinations (Contraindicated)

The co-administration of Nitrolingual akut is formally contraindicated with the following drug classes due to extreme risk of additive vasodilatory effects:

Interaction Class Examples of Prohibited Substances
PDE-5 Inhibitors Sildenafil, Tadalafil, Vardenafil, Avanafil
sGC Stimulators Riociguat

Other Documented Interactions

Interactions that require careful use or monitoring are documented by regulatory authorities:

  • Antihypertensive Medicines: The combination with other agents that lower blood pressure, such as Beta-Adrenergic Blockers and Calcium Channel Blockers, may lead to an additive hypotensive effect and potentially marked orthostatic hypotension.
  • Exposure-Modifying Drugs: Co-administration with Aspirin (Acetylsalicylic Acid) is reported to increase the systemic exposure of nitroglycerin. Conversely, nitroglycerin can increase the oral bioavailability of Ergotamine and related drugs, which should therefore be avoided.
  • Alcohol (Ethanol): The use of alcohol is documented to enhance sensitivity to the hypotensive effects of organic nitrates.
Advertisements

Mechanism of Action

Nitric Oxide Cascade and Enzyme Activation

The drug, Nitroglycerin ( GTN), functions as a prodrug that is rapidly converted inside vascular smooth muscle cells into Nitric Oxide ( NO), an endogenous signaling molecule. The NO binds to and activates the enzyme soluble Guanylate Cyclase ( sGC), initiating the primary molecular cascade. This mechanism acts within domains involving enzyme-mediated signaling, resulting in rapid smooth muscle relaxation.


Vascular Smooth Muscle Relaxation and Venodilation

Activation of sGC leads to a massive increase in the internal messenger cyclic Guanosine Monophosphate ( cGMP). The cGMP cascade promotes the dephosphorylation of contractile proteins within the vascular walls, causing the vascular smooth muscle to relax, a process known as vasodilation. This effect results in rapid modulation of physiological responses; the dilation is preferentially localized to the large systemic veins (venodilation).


Hemodynamic Modulation and Preload Reduction

The pronounced venodilation causes blood volume to be diverted and pooled in the periphery, thereby reducing the quantity and pressure of blood returning to the heart (venous return). This massive decrease in blood volume filling the ventricles is called preload reduction, which immediately alters the heart's workload and oxygen demand—the key physiological adjustment shaping the drug's effect profile.

Advertisements

Dosage and Administration Information

How to Use Nitrolingual akut: Administration Guidelines

Nitrolingual akut is a metered-dose sublingual spray intended for on-demand use. The medicine is administered directly onto or under the tongue and must not be inhaled.


Standard Dosing and Frequency

Administration follows two primary patterns, both using the sublingual route.

Use Pattern Standard Dose Frequency Constraint
Acute Relief One to two metered sprays (400 μg per spray) at the onset of symptoms. May be repeated approximately every five minutes as needed.
Acute Prophylaxis One to two metered sprays. Administered 5 to 10 minutes prior to engaging in a precipitating activity.

No more than three metered sprays are recommended within any 15-minute period. If discomfort persists after the third spray, the user must seek prompt medical attention.


Key Administration Procedures

Specific procedures ensure correct dosing and optimal absorption of the medication:

  • The pump must be primed (e.g., typically five initial sprays) before the first use. Re-priming is required if the spray is unused for specific time periods.
  • The patient should be at rest, preferably in a sitting position, during administration.
  • The mouth should be closed immediately after each dose. To ensure absorption, the user should not swallow or rinse the mouth for approximately 5 to 10 minutes following administration.

Note on Population: Dosage adjustments are not typically specified for older adults or individuals with renal or hepatic impairment, implying the standard adult regimen is generally applicable.

Advertisements

Recent Clinical Evidence

Research Evidence and Studies for Nitroglycerin Sublingual Spray

The Research Framework for Nitroglycerin Sublingual Spray

The research related to sublingual nitroglycerin (the active ingredient in Nitrolingual akut) comprises different types of studies. The evidence includes controlled trials and specialized studies that look at how quickly and the extent to which the medicine is absorbed into the body. Because this medication has been used for a long time, its role is also supported by historical clinical observations and long-standing treatment guidelines. This section will outline the types of research that have been conducted and summarize the information provided by the findings.


Evidence for Acute Relief of Angina Pectoris (Sudden Chest Pain)

The sublingual spray was studied for its use when patients experience sudden or acute chest discomfort. Research explored how symptoms change over time in adults with conditions characterized by fluctuating or episodic manifestations. In this research, investigators observed the time required to record relief and tracked patient-reported outcomes describing perceived discomfort when the spray was administered during episodes of heightened symptom activity.

Clinical literature and practice reports describe the use of sublingual nitroglycerin in the context of initial management for acute chest pain. Studies monitored how symptom changes were observed over brief time intervals following use. Findings were incorporated into major practice guidelines based on the agent's long-standing clinical use.

However, because this use is well-established, there are no recent, large-scale, placebo-controlled clinical trials specifically designed to track acute symptom relief. The long-term effects are not fully established by dedicated follow-up studies that explore the pattern of use for acute episodes over many years.


Evidence for Prophylactic Use (Prevention Before Activity)

The research explored the use of the spray immediately before engaging in physical activities that are known to provoke chest discomfort. These studies utilized Randomized Controlled Trials (RCTs) with a crossover design, involving adults with Chronic Stable Angina. The research examined outcomes reflecting daily functioning or activity level by observing participants during controlled Exercise Tolerance Tests (ETTs).

Studies reported patterns where the measurements for time until symptoms of physical discomfort were recorded during controlled exercise differed between participants who received the spray and those who received placebo. Because these studies focused on surrogate endpoints (measurable changes in exercise capacity), the impact on long-term clinical outcomes, such as hospitalization or survival rates, is not fully established.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Nitrolingual akut (FAQ)


Q: Does Nitrolingual akut work right away?

According to official product information, the onset of the medicine's vasodilatory (blood vessel widening) effect is reported to occur approximately one to three minutes after it is administered under the tongue. This rapid action is key to the product's function for the acute management of sudden symptoms.


Q: How long does the effect of Nitrolingual akut last?

Regulatory information indicates that the vasodilatory effect of the spray reaches its maximum approximately five minutes after use. While the drug's mean half-life (the time it takes for half the drug to leave the body) is reported to be two to three minutes, the information available regarding duration is related to its acute, on-demand use.


Q: Is it normal to feel a tingling or burning sensation after using the spray?

Yes, official safety information for nitroglycerin products states that the medicine may produce a common burning or tingling sensation when it is administered under the tongue. This is an expected and described characteristic of the sublingual administration route for this type of medication.


Q: Can I take Nitrolingual akut if I already take blood pressure medication?

Regulatory documents state that using this spray alongside other agents that lower blood pressure, such as beta-adrenergic blockers or calcium channel blockers, may result in an additive hypotensive effect (a combined drop in blood pressure). Official product information suggests that individuals using antihypertensive medicines be monitored for this potential effect.


Q: Can older adults use Nitrolingual akut safely?

Official documentation indicates that the standard adult regimen is generally applicable to older adults. However, product information also notes that older adults may have an increased susceptibility to hypotensive effects, meaning they may be more likely to experience low blood pressure.


Q: Why do some people say they get dizzy after using the spray?

Dizziness and lightheadedness are listed as common adverse reactions in official safety documents. This feeling is often reported to result from orthostatic hypotension, which is a drop in blood pressure that can occur when a person stands up or changes position.


Q: How should I carry the Nitrolingual akut spray with me?

To maintain the spray's stability and safety, regulatory guidelines mandate that the medicine must be kept in its original container at all times. It is also an explicit requirement that the spray must be kept out of the sight and reach of children.


Q: Does the spray need to be kept in the refrigerator?

No. Official guidelines state that the product must be stored at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). The medicine must not be refrigerated or frozen.


Q: Does Nitrolingual akut contain any common allergens?

The spray contains the active ingredient nitroglycerin along with excipients, such as ethanol. Official labeling includes a specific warning that the medicine is contraindicated for patients with a known hypersensitivity or allergic reaction to nitroglycerin or other nitrates.


Q: Are there any food or drinks that interact with Nitrolingual akut?

Regulatory information specifically documents that the use of alcohol (ethanol) may enhance a person's sensitivity to the drug's hypotensive effects (low blood pressure). The use of the medicine with alcohol is generally avoided based on the documented interaction.


Q: Is it safe to drive after using Nitrolingual akut?

Due to the potential for common side effects such as dizziness, low blood pressure, and fainting, regulatory information advises patients to avoid driving or operating hazardous machinery until they know how the medication affects them.


Q: Is Nitrolingual akut the same as Nitrostat?

Nitrolingual akut and Nitrostat are both brand names for products containing the active ingredient nitroglycerin, which is used to relieve acute chest discomfort. However, they represent different sublingual dosage forms, with Nitrolingual akut being a spray and Nitrostat typically being a sublingual tablet.


Q: What happens if I accidentally swallow the spray instead of holding it under your tongue?

Official administration guidelines state the spray should not be swallowed. This is because the sublingual route, under the tongue, is considered critical for rapid and efficient absorption. Swallowing would allow the drug to undergo initial metabolic breakdown in the liver, which is avoided by the intended sublingual route.


Q: Can women who are breastfeeding use Nitrolingual akut?

Regulatory information notes that sublingual and intravenous forms of the active ingredient have not been specifically studied during breastfeeding. The official guidance states that use is considered only if clearly necessary, with observation of the infant for potential adverse effects.


Q: Is Nitrolingual akut addictive?

Official regulatory documents do not address addiction. However, they do note the possibility of developing a tolerance (decreased effectiveness) if high continuous doses are maintained for prolonged periods. This factor is noted in the context of avoiding high, continuous doses.


Q: Does the spray cause dry mouth?

Dry mouth, clinically referred to as Xerostomia, has been listed in product information as a common adverse effect associated with nitroglycerin sublingual products.


Q: What is the difference between this and nitroglycerin patches?

Nitrolingual akut sublingual spray is indicated for the acute relief of sudden symptoms because of its rapid absorption. In contrast, nitroglycerin patches are a different form of treatment that are used for the prevention (prophylaxis) of episodes and are not intended to treat an attack once it has started.


Q: Can I use Nitrolingual akut before exercise?

Official regulatory instructions state that the spray may be used for prophylaxis (prevention) of symptoms. The official instructions indicate administration 5 to 10 minutes prior to engaging in physical activities that are known to cause an acute attack.


Q: How is the safety of Nitrolingual akut classified by regulatory bodies?

The active ingredient in the spray, nitroglycerin, is classified by the US Food and Drug Administration (FDA) as a Pregnancy Category C substance. This category is used to inform about risk during pregnancy.


Q: Why does the packaging say to avoid heat or open flame?

The packaging requires avoidance of excessive heat and open flame due to the nature of the pressurized container and the volatility of the components. The product contains nitroglycerin in an alcoholic solvent and should not be punctured or incinerated.


Q: Can I use Nitrolingual akut if I am taking over-the-counter supplements?

The drug interaction information focuses primarily on prescription medicines; however, some supplements, such as Hawthorn or L-arginine, are noted to potentially affect blood pressure. The drug interaction information in official sources should be consulted.


Q: Is there any difference in how Nitrolingual akut works for men vs. women?

Available pharmacological information suggests that the pharmacokinetics (how the body absorbs and processes the drug) of organic nitrates are not influenced by a person's gender or age.


Q: What is known about the research evidence for using this drug for its intended purpose?

Research evidence for sublingual nitroglycerin products primarily includes controlled trials and long-standing clinical observations that support its use for acute symptom relief. Randomized controlled trials have also been used to study its use for prevention (prophylaxis) before physical activity.


Q: Can I accidentally spray too much Nitrolingual akut?

Official product information includes a section documenting the signs and symptoms associated with an overdose. If too many sprays are used, this may cause adverse effects such as a severe throbbing headache, confusion, a severe drop in blood pressure, and possible fainting.

Advertisements

How should Nitrolingual akut be stored and disposed of?

How to Store and Dispose of Nitrolingual akut?

Official regulatory guidelines define specific conditions for storing and discarding the Nitrolingual akut spray to maintain its stability and safety. The product must be stored at controlled room temperature, typically between 20 C and 25 C, and must not be refrigerated or frozen. Protection from excessive heat and open flame is mandatory, and the product must remain in its original container.

Because the canister is pressurized, it should not be punctured or burned. To ensure child safety, it is an explicit requirement to keep the spray out of the sight and reach of children.

Handling & Disposal Mandates
Storage Temperature Controlled room temperature (20 C to 25 C)
Prohibited Refrigeration, freezing, or exposure to open flames.
Disposal Rule Unused or expired product must not be placed in household trash or wastewater. Dispose according to local pharmaceutical regulations.
Container Safety Do not puncture or incinerate the pressurized canister.

If the spray has not been used for an extended period, such as six weeks, it may require re-priming before the next dose is administered.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nitrolingual akut found in:

A-Z Index: